| Price | 525.00p on 21-07-2026 at 10:00:22 |
|---|---|
| Change | 0.00p 0% |
| Buy | 550.00p |
| Sell | 500.00p |
| Last Trade: | Sell 22.00 at 500.00p |
| Day's Volume: | 22 |
| Last Close: | 525.00p |
| Open: | 525.00p |
| ISIN: | GB00BMCLYF79 |
| Day's Range | 525.00p - 525.00p |
| 52wk Range: | 425.00p - 1,020.00p |
| Market Capitalisation: | £81.30m |
| VWAP: | 500.00p |
| Shares in Issue: | 15.48m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
4basebio Plc (4BB) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 22 | 500.00p | Ordinary |
08:04:53 - 21-Jul-26 |
| Sell* | 96 | 519.75p | Ordinary |
13:42:24 - 20-Jul-26 |
| Sell* | 237 | 500.50p | Ordinary |
09:53:51 - 20-Jul-26 |
| Sell* | 6 | 500.50p | Ordinary |
08:30:21 - 20-Jul-26 |
| Sell* | 8 | 519.75p | Ordinary |
08:00:31 - 20-Jul-26 |
| Sell* | 27 | 500.00p | Ordinary |
15:06:22 - 17-Jul-26 |
| Buy* | 49 | 550.00p | Ordinary |
15:04:19 - 17-Jul-26 |
| Sell* | 3 | 500.00p | Ordinary |
11:29:41 - 17-Jul-26 |
| Sell* | 5 | 519.75p | Ordinary |
16:10:44 - 16-Jul-26 |
| Sell* | 88 | 500.50p | Ordinary |
15:54:38 - 16-Jul-26 |
4basebio Plc (4BB) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 8th Jul 2026 7:00 am | PRN | Director Appointment |
| 30th Jun 2026 5:37 pm | PRN | Result of AGM & Issue of Options |
| 16th Jun 2026 7:00 am | PRN | Notice of Investor Presentation |
| 15th Jun 2026 7:00 am | PRN | 4basebio Appoints Dr. Jeff Coller to Strategic Advisory Board |
| 5th Jun 2026 7:00 am | PRN | Notice of Annual General Meeting |
| 22nd May 2026 9:10 am | PRN | Director Dealing |
| 20th May 2026 7:02 am | PRN | Final Results and Notice of AGM |
| 20th May 2026 7:00 am | PRN | 4basebio Signs Clinical Supply Agreement to Support Phase II Clinical Trial |
| 14th May 2026 7:00 am | PRN | Appointment of Chief Financial Officer and Board Changes |
| 11th May 2026 7:00 am | PRN | 4basebio Launches Enzymatic ssDNA Platform |